The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
The Advisory Committee on Immunization Practices, or ACIP, voted separately on thimerosal-containing flu shots for children, pregnant women and adults. All three recommendations passed with a 5-1 vote and one abstention. Thimerosal was removed from all routine childhood vaccines in 2001, but is still used in some flu shots, including those given to children and pregnant women.
Pope Leo XIV condemned the suicide bombing at a Damascus church, calling it “a cowardly terrorist attack” as he appealed to the international community not to give up on Syria.
Referral to AHPRA Concerning Dr Michelle Telfer Concerning Conduct Revealed in Re Devin [2025] FedCFamC1F 211 Judgment – Request for Investigation Under the National Law
U.S. Attorney General Pam Bondi said Monday that the DOJ “will use every legal and constitutional tool available to ensure Americans can live out their faith freely without fear.” Many health freedom advocates hope Bondi’s pledge will result in schools in all 50 states honoring religious exemptions from vaccine mandates.
In her resignation letter, Dr. Fiona Havers cited concerns about the future of vaccine policy under HHS Secretary Robert F. Kennedy Jr. Havers is the second CDC vaccine expert to resign in under two weeks.
A ‘nonbinary’ lecturer advised nursing students at Mount St. Mary College in New York to ‘take the patient’s lead’ when considering giving puberty blockers.
HHS Secretary Robert F. Kennedy Jr. announced late today that he is retiring all 17 members of the CDC vaccine advisory committee. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy wrote in an op-ed published today in The Wall Street Journal.
